Davidson Capital Management’s Boston Scientific BSX Stock Holding History

Davidson Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.63M	Buy	61,549 +3,933	+7%	+$214K	0.42%	55
2026 Q1	$3.62M	Buy	57,616 +57,486	+44,220%	+$4.6M	0.66%	47
2025 Q4	$12.4K	Buy	+130	New	+$12.7K	﹤0.01%	71
2023 Q1	–	Sell	-52	Closed	-$2.41K	–	90
2022 Q4	$2.41K	Buy	+52	New	+$2.25K	﹤0.01%	109

Other funds holding BSX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Milford Funds Auckland $6.14B AUM

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Banque Transatlantique Paris, France $4.66B AUM 33.26% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Davidson Capital Management's BSX Position: Q2 2026 in Review

Davidson Capital Management increased its Boston Scientific (BSX) stake by 6.8% in Q2 2026, buying an estimated $214K and bringing the position to 61,549 shares worth $2.63M. The position accounts for 0.42% of the portfolio, ranked #55.

Davidson Capital Management first reported a position in BSX in Q4 2022 and has held it in 4 quarters since. The position peaked at $3.62M in Q1 2026. 495 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Davidson Capital Management held 61,549 shares of Boston Scientific worth $2.63M as of Q2 2026.
Davidson Capital Management bought 3,933 Boston Scientific shares in Q2 2026, an estimated $214K.
Boston Scientific made up 0.42% of Davidson Capital Management's portfolio in Q2 2026, its #55 holding.
Davidson Capital Management first reported a position in Boston Scientific in Q4 2022 and has held it in 4 quarters since.
Davidson Capital Management's Boston Scientific position peaked at $3.62M in Q1 2026.
495 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Davidson Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.